Learn More
Selleck Chemical LLC Cu-CPT22

Supplier: Selleck Chemical LLC S867710MM/1ML
CU-CPT22 shows dose-dependent inhibitory effects blocking Pam3CSK4-induced TLR1/2 activation with an IC50 of 0 58 0 09 M while no significant inhibition to TLR2/6 It demonstrates minimal non-specific inhibition against a panel of 10 representative kinases (PDGFRB MET DDR2 SRC MAPK1 PAK1 AKT1 PKC- CAMK1 and PLK4)
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.